PKM and neoplasm: The pharmacologic ascorbate treatment did not cause any change in the mRNA expression of PKM2, but it inhibited the phosphorylation of PKM2 at Ser37 [24] that halted the nuclear translocation of PKM2, suggesting that pharmacological ascorbate exerted its selective anti-tumour activity at least partly through the Warburg effect.